NM_002900.3:c.1037G>A

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_002900.3(RBP3):​c.1037G>A​(p.Arg346His) variant causes a missense change. The variant allele was found at a frequency of 0.0122 in 1,612,944 control chromosomes in the GnomAD database, including 147 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 7 hom., cov: 33)
Exomes 𝑓: 0.013 ( 140 hom. )

Consequence

RBP3
NM_002900.3 missense

Scores

2
2
3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:7

Conservation

PhyloP100: 4.25
Variant links:
Genes affected
RBP3 (HGNC:9921): (retinol binding protein 3) Interphotoreceptor retinol-binding protein is a large glycoprotein known to bind retinoids and found primarily in the interphotoreceptor matrix of the retina between the retinal pigment epithelium and the photoreceptor cells. It is thought to transport retinoids between the retinal pigment epithelium and the photoreceptors, a critical role in the visual process.The human IRBP gene is approximately 9.5 kbp in length and consists of four exons separated by three introns. The introns are 1.6-1.9 kbp long. The gene is transcribed by photoreceptor and retinoblastoma cells into an approximately 4.3-kilobase mRNA that is translated and processed into a glycosylated protein of 135,000 Da. The amino acid sequence of human IRBP can be divided into four contiguous homology domains with 33-38% identity, suggesting a series of gene duplication events. In the gene, the boundaries of these domains are not defined by exon-intron junctions, as might have been expected. The first three homology domains and part of the fourth are all encoded by the first large exon, which is 3,180 base pairs long. The remainder of the fourth domain is encoded in the last three exons, which are 191, 143, and approximately 740 base pairs long, respectively. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.085944325).
BP6
Variant 10-47349521-G-A is Benign according to our data. Variant chr10-47349521-G-A is described in ClinVar as [Benign]. Clinvar id is 208300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-47349521-G-A is described in Lovd as [Likely_benign]. Variant chr10-47349521-G-A is described in Lovd as [Benign]. Variant chr10-47349521-G-A is described in Lovd as [Likely_pathogenic].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00762 (1160/152260) while in subpopulation NFE AF= 0.0137 (931/68008). AF 95% confidence interval is 0.013. There are 7 homozygotes in gnomad4. There are 528 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBP3NM_002900.3 linkc.1037G>A p.Arg346His missense_variant Exon 1 of 4 ENST00000584701.2 NP_002891.1 P10745

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBP3ENST00000584701.2 linkc.1037G>A p.Arg346His missense_variant Exon 1 of 4 1 NM_002900.3 ENSP00000463151.1 P10745

Frequencies

GnomAD3 genomes
AF:
0.00762
AC:
1160
AN:
152142
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00232
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00523
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.00575
GnomAD3 exomes
AF:
0.00735
AC:
1830
AN:
248946
Hom.:
15
AF XY:
0.00752
AC XY:
1016
AN XY:
135092
show subpopulations
Gnomad AFR exome
AF:
0.00217
Gnomad AMR exome
AF:
0.00434
Gnomad ASJ exome
AF:
0.000898
Gnomad EAS exome
AF:
0.00109
Gnomad SAS exome
AF:
0.00154
Gnomad FIN exome
AF:
0.00414
Gnomad NFE exome
AF:
0.0128
Gnomad OTH exome
AF:
0.00867
GnomAD4 exome
AF:
0.0127
AC:
18578
AN:
1460684
Hom.:
140
Cov.:
34
AF XY:
0.0124
AC XY:
9001
AN XY:
726640
show subpopulations
Gnomad4 AFR exome
AF:
0.00260
Gnomad4 AMR exome
AF:
0.00505
Gnomad4 ASJ exome
AF:
0.000880
Gnomad4 EAS exome
AF:
0.000353
Gnomad4 SAS exome
AF:
0.00165
Gnomad4 FIN exome
AF:
0.00498
Gnomad4 NFE exome
AF:
0.0154
Gnomad4 OTH exome
AF:
0.0122
GnomAD4 genome
AF:
0.00762
AC:
1160
AN:
152260
Hom.:
7
Cov.:
33
AF XY:
0.00709
AC XY:
528
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.00231
Gnomad4 AMR
AF:
0.00523
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.000580
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00245
Gnomad4 NFE
AF:
0.0137
Gnomad4 OTH
AF:
0.00569
Alfa
AF:
0.0104
Hom.:
9
Bravo
AF:
0.00776
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RBP3: BS1, BS2 -

not specified Benign:2
May 04, 2022
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Retinitis pigmentosa 66 Uncertain:1
Jun 27, 2013
ClinVar Staff, National Center for Biotechnology Information (NCBI)
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Retinitis pigmentosa Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_noAF
Pathogenic
0.40
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.28
T
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.086
T
Sift4G
Uncertain
0.0070
D
Vest4
0.66
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111245635; hg19: chr10-48389841; API